Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4
- PMID: 17142351
- DOI: 10.1152/ajplung.00226.2006
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4
Abstract
Human lung fibroblasts express proteinase-activated receptor-1 (PAR1), PAR2 and PAR3, but not PAR4. Because PAR2 has inflammatory effects on human primary bronchial fibroblasts (HPBF), we asked 1) whether the inflammatory mediators TNF-alpha and LPS could modify HPBF PAR expression and 2) whether modified PAR expression altered HPBF responsiveness to PAR agonists in terms of calcium signaling and cell growth. TNF-alpha and LPS induced PAR4 mRNA expression (RT-PCR) at 6 h and 24 h, respectively. TNF-alpha and LPS also upregulated PAR2 mRNA expression with similar kinetics but had negligible effect on PAR1 and PAR3. Flow cytometry for PAR1, PAR2, and PAR3 also demonstrated selective PAR2 upregulation in response to TNF-alpha and LPS. Intracellular calcium signaling to SLIGKV-NH2 (a selective PAR2-activating peptide; PAR2-AP) and AYPGQV-NH2 (PAR4-AP) revealed that TNF-alpha and LPS induced maximal responses to these PAR agonists at 24 h and 48 h, respectively. Upregulation of PAR2 by TNF-alpha heightened HPBF responses to trypsin, while PAR4 induction enabled cathepsin-G-mediated calcium signaling. Cathepsin-G also disarmed PAR1 and PAR2 in HPBF, while tryptase disarmed PAR2. Induction of PAR4 also enabled thrombin to elicit a calcium signal through both PAR1 and PAR4, as determined by a desensitization assay. In cell growth assays the PAR4 agonists cathepsin-G and AYPGQV-NH2 reduced HPBF cell number only in TNF-alpha-treated HPBF. Moreover, the mitogenic effect of thrombin (a PAR1/PAR4 agonist) but not the PAR1-AP TFLLR-NH2, was ablated in TNF-alpha-treated HPBF. These findings point to an important mechanism, whereby cellular responses to thrombin and cathepsin-G can be modified during an inflammatory response.
Similar articles
-
Proteinase-activated receptor2 agonists upregulate granulocyte colony-stimulating factor, IL-8, and VCAM-1 expression in human bronchial fibroblasts.Am J Respir Cell Mol Biol. 2006 Jul;35(1):133-41. doi: 10.1165/rcmb.2005-0362OC. Epub 2006 Feb 23. Am J Respir Cell Mol Biol. 2006. PMID: 16498082
-
Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.Regul Pept. 2014 Feb 10;189:46-50. doi: 10.1016/j.regpep.2014.03.001. Epub 2014 Mar 11. Regul Pept. 2014. PMID: 24631471
-
Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists.Circ Res. 2001 Jul 6;89(1):92-8. doi: 10.1161/hh1301.092661. Circ Res. 2001. PMID: 11440983
-
Cofactoring and dimerization of proteinase-activated receptors.Pharmacol Rev. 2013 Sep 24;65(4):1198-213. doi: 10.1124/pr.111.004747. Print 2013. Pharmacol Rev. 2013. PMID: 24064459 Free PMC article. Review.
-
Molecular mechanisms regulating Proteinase-Activated Receptors (PARs).FEBS J. 2021 Apr;288(8):2697-2726. doi: 10.1111/febs.15829. Epub 2021 Apr 6. FEBS J. 2021. PMID: 33742547 Review.
Cited by
-
Protease-activated receptor 4: from structure to function and back again.Br J Pharmacol. 2016 Oct;173(20):2952-65. doi: 10.1111/bph.13455. Epub 2016 Mar 10. Br J Pharmacol. 2016. PMID: 26844674 Free PMC article. Review.
-
Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.J Am Heart Assoc. 2020 Jun 16;9(12):e015616. doi: 10.1161/JAHA.119.015616. Epub 2020 Jun 4. J Am Heart Assoc. 2020. PMID: 32495720 Free PMC article.
-
Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.Hypertens Res. 2021 Oct;44(10):1261-1273. doi: 10.1038/s41440-021-00700-7. Epub 2021 Jul 20. Hypertens Res. 2021. PMID: 34285375
-
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S263-82. doi: 10.1038/sj.bjp.0707507. Epub 2007 Dec 3. Br J Pharmacol. 2008. PMID: 18059329 Free PMC article. Review.
-
N-linked glycosylation regulates human proteinase-activated receptor-1 cell surface expression and disarming via neutrophil proteinases and thermolysin.J Biol Chem. 2011 Jul 1;286(26):22991-3002. doi: 10.1074/jbc.M110.204271. Epub 2011 May 6. J Biol Chem. 2011. PMID: 21550978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources